229 related articles for article (PubMed ID: 27869165)
1. TAp63 suppresses mammary tumorigenesis through regulation of the Hippo pathway.
Su X; Napoli M; Abbas HA; Venkatanarayan A; Bui NHB; Coarfa C; Gi YJ; Kittrell F; Gunaratne PH; Medina D; Rosen JM; Behbod F; Flores ER
Oncogene; 2017 Apr; 36(17):2377-2393. PubMed ID: 27869165
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis.
Li H; Gumbiner BM
Mamm Genome; 2016 Dec; 27(11-12):556-564. PubMed ID: 27601049
[TBL] [Abstract][Full Text] [Related]
3. p63 is a prosurvival factor in the adult mammary gland during post-lactational involution, affecting PI-MECs and ErbB2 tumorigenesis.
Yallowitz AR; Alexandrova EM; Talos F; Xu S; Marchenko ND; Moll UM
Cell Death Differ; 2014 Apr; 21(4):645-54. PubMed ID: 24440910
[TBL] [Abstract][Full Text] [Related]
4. p63 Sustains self-renewal of mammary cancer stem cells through regulation of Sonic Hedgehog signaling.
Memmi EM; Sanarico AG; Giacobbe A; Peschiaroli A; Frezza V; Cicalese A; Pisati F; Tosoni D; Zhou H; Tonon G; Antonov A; Melino G; Pelicci PG; Bernassola F
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3499-504. PubMed ID: 25739959
[TBL] [Abstract][Full Text] [Related]
5. Plk1 regulates liver tumor cell death by phosphorylation of TAp63.
Komatsu S; Takenobu H; Ozaki T; Ando K; Koida N; Suenaga Y; Ichikawa T; Hishiki T; Chiba T; Iwama A; Yoshida H; Ohnuma N; Nakagawara A; Kamijo T
Oncogene; 2009 Oct; 28(41):3631-41. PubMed ID: 19668228
[TBL] [Abstract][Full Text] [Related]
6. TAp63 induces senescence and suppresses tumorigenesis in vivo.
Guo X; Keyes WM; Papazoglu C; Zuber J; Li W; Lowe SW; Vogel H; Mills AA
Nat Cell Biol; 2009 Dec; 11(12):1451-7. PubMed ID: 19898465
[TBL] [Abstract][Full Text] [Related]
7. Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation.
Napoli M; Li X; Ackerman HD; Deshpande AA; Barannikov I; Pisegna MA; Bedrosian I; Mitsch J; Quinlan P; Thompson A; Rajapakshe K; Coarfa C; Gunaratne PH; Marchion DC; Magliocco AM; Tsai KY; Flores ER
Nat Commun; 2020 Oct; 11(1):5156. PubMed ID: 33056990
[TBL] [Abstract][Full Text] [Related]
8. Hippo pathway in mammary gland development and breast cancer.
Shi P; Feng J; Chen C
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):53-9. PubMed ID: 25467757
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway.
Salah Z; Itzhaki E; Aqeilan RI
Oncotarget; 2014 Nov; 5(21):10886-900. PubMed ID: 25350971
[TBL] [Abstract][Full Text] [Related]
10. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs.
Su X; Chakravarti D; Cho MS; Liu L; Gi YJ; Lin YL; Leung ML; El-Naggar A; Creighton CJ; Suraokar MB; Wistuba I; Flores ER
Nature; 2010 Oct; 467(7318):986-90. PubMed ID: 20962848
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer.
Dusek RL; Bascom JL; Vogel H; Baron S; Borowsky AD; Bissell MJ; Attardi LD
Breast Cancer Res; 2012 Apr; 14(2):R65. PubMed ID: 22515648
[TBL] [Abstract][Full Text] [Related]
12. Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
Liu J; Li J; Li P; Wang Y; Liang Z; Jiang Y; Li J; Feng C; Wang R; Chen H; Zhou C; Zhang J; Yang J; Liu P
Sci Rep; 2017 Feb; 7():42125. PubMed ID: 28169360
[TBL] [Abstract][Full Text] [Related]
13. TAp63 is a master transcriptional regulator of lipid and glucose metabolism.
Su X; Gi YJ; Chakravarti D; Chan IL; Zhang A; Xia X; Tsai KY; Flores ER
Cell Metab; 2012 Oct; 16(4):511-25. PubMed ID: 23040072
[TBL] [Abstract][Full Text] [Related]
14. Hippo signaling promotes JNK-dependent cell migration.
Ma X; Wang H; Ji J; Xu W; Sun Y; Li W; Zhang X; Chen J; Xue L
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):1934-1939. PubMed ID: 28174264
[TBL] [Abstract][Full Text] [Related]
15. A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis.
Chen Q; Zhang N; Gray RS; Li H; Ewald AJ; Zahnow CA; Pan D
Genes Dev; 2014 Mar; 28(5):432-7. PubMed ID: 24589775
[TBL] [Abstract][Full Text] [Related]
16. EMT programs promote basal mammary stem cell and tumor-initiating cell stemness by inducing primary ciliogenesis and Hedgehog signaling.
Guen VJ; Chavarria TE; Kröger C; Ye X; Weinberg RA; Lees JA
Proc Natl Acad Sci U S A; 2017 Dec; 114(49):E10532-E10539. PubMed ID: 29158396
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis.
Chao CH; Chang CC; Wu MJ; Ko HW; Wang D; Hung MC; Yang JY; Chang CJ
J Clin Invest; 2014 Jul; 124(7):3093-106. PubMed ID: 24911147
[TBL] [Abstract][Full Text] [Related]
19. DNA-binding and transactivation activities are essential for TAp63 protein degradation.
Ying H; Chang DL; Zheng H; McKeon F; Xiao ZX
Mol Cell Biol; 2005 Jul; 25(14):6154-64. PubMed ID: 15988026
[TBL] [Abstract][Full Text] [Related]
20. Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes.
Abbas HA; Bui NHB; Rajapakshe K; Wong J; Gunaratne P; Tsai KY; Coarfa C; Flores ER
Cancer Res; 2018 Jan; 78(2):451-462. PubMed ID: 29180475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
